Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLC

Clinical trial NCT03527251 · UNKNOWN

Trial details

NCT number: NCT03527251
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2018-05-15
Primary completion: 2018-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.